前列腺癌治疗中的免疫疗法和基因疗法。
Immunotherapy and gene therapy in prostate cancer treatment.
作者信息
Grozescu T, Popa F
机构信息
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
出版信息
J Med Life. 2017 Jan-Mar;10(1):54-55.
Abstract
There are few methods bringing several relatively recent advances in therapy of certain types of prostate cancer. Belonging to personalized therapies, they use cells (normal or pathologic) from the patient, modify and reintroduce them in the patient's body, leading to an increased efficiency against the neoplastic tissue, proving to increase the patient's lifespan and/ or tumor progression.
摘要
在某些类型前列腺癌的治疗方面，带来多项相对较新进展的方法寥寥无几。作为个性化疗法，它们利用患者的细胞（正常或病变），对其进行改造后再重新引入患者体内，从而提高对肿瘤组织的治疗效果，事实证明这能延长患者寿命和/或延缓肿瘤进展。
相似文献
1
Immunotherapy and gene therapy in prostate cancer treatment.前列腺癌治疗中的免疫疗法和基因疗法。
J Med Life. 2017 Jan-Mar;10(1):54-55.
2
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.前列腺癌免疫疗法，尤其是与雄激素剥夺疗法或放射治疗联合使用时。采用定制的药物基因组学方法来克服免疫疗法对癌症的耐药性。
G Chir. 2017 Sep-Oct;37(5):225-235. doi: 10.11138/gchir/2016.37.5.225.
3
Immune Checkpoint Therapies in Prostate Cancer.前列腺癌中的免疫检查点疗法
Cancer J. 2016 Mar-Apr;22(2):117-20. doi: 10.1097/PPO.0000000000000176.
4
Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer.
J Urol. 2001 Oct;166(4):1316-21. doi: 10.1016/s0022-5347(05)65760-6.
5
[Immunotherapy of prostate cancer].[前列腺癌的免疫疗法]
Urologe A. 1993 Sep;32(5):382-9.
6
Immunotherapy for prostate cancer: what's the future?前列腺癌的免疫疗法：未来何去何从？
Hematol Oncol Clin North Am. 2006 Aug;20(4):965-83, xi. doi: 10.1016/j.hoc.2006.03.003.
7
Development of PROSTVAC immunotherapy in prostate cancer.前列腺癌中PROSTVAC免疫疗法的发展
Future Oncol. 2015;11(15):2137-48. doi: 10.2217/fon.15.120.
8
Viral based gene therapy for prostate cancer.基于病毒的前列腺癌基因治疗。
Curr Gene Ther. 2001 Jul;1(2):183-200. doi: 10.2174/1566523013348742.
9
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.人类前列腺癌的免疫景观：免疫逃逸机制和个性化免疫治疗的生物标志物。
BMC Cancer. 2020 Jun 18;20(1):572. doi: 10.1186/s12885-020-07058-y.
10
Advances in prostate cancer immunotherapy.
Surg Oncol. 2002 Jun;11(1-2):35-45. doi: 10.1016/s0960-7404(02)00012-9.
引用本文的文献
1
Reduced pim-1 expression increases chemotherapeutic drug sensitivity in human androgen-independent prostate cancer cells by inducing apoptosis.Pim-1表达降低通过诱导凋亡增加人雄激素非依赖性前列腺癌细胞对化疗药物的敏感性。
Exp Ther Med. 2019 Oct;18(4):2731-2738. doi: 10.3892/etm.2019.7862. Epub 2019 Aug 7.
本文引用的文献
1
Prostate cancer vaccines: Update on clinical development.前列腺癌疫苗：临床开发进展
Oncoimmunology. 2013 May 1;2(5):e24523. doi: 10.4161/onci.24523. Epub 2013 Apr 29.
2
Physician Data Query (PDQ(R)) update.医师数据查询（PDQ(R)）更新。
J Natl Cancer Inst. 2012 May 2;104(9):655-6. doi: 10.1093/jnci/djs231. Epub 2012 Apr 18.
3
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
Zotero 插件